By the early 1980s there was increasing concern about Upjohn revenues and profits, which were being maintained only because of tax-favorable treatment in the Puerto Rico manufacturing plant. The document below summarizes the turnaround strategy created in 1984. The slides after the document give some interesting information about the pharma industry in the early 1980s.